You can find the annual or quarterly income statement of Caris Life Sciences Inc here for insights into the performance and operational efficiency of Caris Life Sciences Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

Total revenue

--292.89M

--216.83M

--181.40M

--120.92M

Revenue

--292.89M

--216.83M

----

--120.92M

Cost of revenue

--71.97M

--69.33M

--67.71M

--63.85M

Operating expenses

--204.47M

--184.19M

--199.39M

--178.87M

R&D expenses

--31.84M

--21.62M

--25.05M

--23.07M

Depreciation, depletion, and amortization

--4.29M

--4.87M

--6.41M

--7.04M

Other operating expenses

----

--1.00K

Operating profit

--88.41M

--32.64M

---17.99M

---57.95M

Net non-operating interest income (expenses)

Non-operating interest income

--7.01M

--7.36M

--1.62M

--503.00K

Non-operating interest expense

--11.36M

--13.51M

--19.21M

--12.78M

Special income (expenses)

---1.97M

---2.08M

---35.80M

---32.33M

Other non-operating income (expenses)

---148.00K

---89.00K

---411.00K

---17.00K

Income before tax

--81.96M

--24.32M

---71.79M

---102.58M

Income tax

--0.00

Income after tax

--81.96M

--24.32M

---71.79M

---102.58M

Net income from continuous operations

--81.96M

--24.32M

---71.79M

---102.58M

Net income attributable to controlling interests

--81.96M

--24.32M

---517.20M

---127.04M

Preferred share dividend

--0.00

--384.44M

--24.46M

Net income attributable to common shareholders

--81.96M

--24.32M

---517.20M

---127.04M

Basic earnings per share

--0.29

--0.09

---1.84

---0.46

Diluted earnings per share

--0.29

--0.08

---1.84

---0.46

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

